Clal Biotechnology | CBI - Assets

Stock Price
31.90
Daily Change
1.00 3.24%
Monthly
5.63%
Yearly
5.28%
Q2 Forecast
29.98

Clal Biotechnology reported ILS158.39M in Assets for its fiscal quarter ending in December of 2023.





Assets Change Date
Arca Biopharma USD 488.62M 20.63M Dec/2025
aTyr Pharma USD 515.34M 408.68M Dec/2025
Bio Path USD 690K 56K Sep/2025
Brainstorm Cell Therapeutics USD 1.02M 358K Dec/2025
Cara Therapeutics USD 39.02M 4.73M Sep/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
Immunic USD 40.7M 20.72M Sep/2025
Infinity Pharmaceuticals USD 21.23M 8.72M Jun/2023
Minerva Neurosciences USD 97.97M 69.88M Dec/2025
RedHill Biopharma USD 18.38M 332K Jun/2025
TherapeuticsMD USD 40.13M 1.96M Jun/2024